<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573097/" ref="ordinalpos=576&amp;ncbi_uid=4674652&amp;link_uid=PMC3573097" image-link="/pmc/articles/PMC3573097/figure/pgen-1003253-g007/" class="imagepopup">Figure 7. RIOK1 and RIOK2 are required for EGFR- and PI3K-mediated tumorigenesis..  From: A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt <span class="highlight" style="background-color:">Signaling</span> in Glioblastoma. </a></div><br /><div class="p4l_captionBody">Pathway diagram placing RIOK1 and RIOK2 in relation to Akt downstream of EGFR and PI3K signaling in GBM. RIOK2 mediates signaling both upstream and downstream of Akt via stimulation of TORC2 (left). Loss of RIOK1 or RIOK2 reduces Akt signaling downstream of oncogenic EGFR and PI3K signaling, and induces the p53-dependent ribosomal stress checkpoint via RpL11 (right).</div></div>